مقایسه شاخص های Deformation بافتی شریان پولمونر در افراد با فشار شریان پولمونر بالا با افراد با فشار شریان پولمونر نرمال در بیمارستان شریعتی سال 94-95


۱۲ مهر ۱۳۹۶

Title: assessment of Longitudinal deformation indices of pulmonary artery in patients with pulmonary hypertension versus normal patients

 

Abstract:

Objectives:

In this study, pulmonary artery longitudinal deformation indices were evaluated in patients with pulmonary hypertension and compared to normal subjects to delineate the effect of high pulmonary pressure on vessel wall characteristic

 

Methods:

15 patient with diagnosis of pulmonary hypertension and 15 healthy individual were evaluated .In parasternal short axis view at the level of aortic valve, longitudinal axis of pulmonary artery was obtained and velocity, strain and strain rate at different level of vessel wall was measured by color coded doppler   myocardial imaging

 

Results:

The systolic strain was positive in most segments of both normal and pulmonary hypertension groups. Negative strain was only in some parts of proximal segments in normal group, but was defined in other parts of vessel wall in PH group.

Amount of velocity, strain and strain rate was significantly lower in PH group, mostly in medial wall.

 

Conclusion:

This study evaluated the deformation indices of pulmonary artery in pulmonary  hypertension in comparison to normal subjects. This was the first study by color coded Doppler myocardial imaging and found significant reduction of velocity , strain and strain rate in PH group.

 

Keywords:

 Pulmonary artery, Pulmonary artery hypertension, Strain, Strain rate, Doppler Echocardiography

 

فهرست منابع و ماخذ فارسي و لاتين:

مرجع

1.         Farber, H.W. and J. Loscalzo, Pulmonary arterial hypertension. New England Journal of Medicine, 2004. 351(16): p. 1655-1665.

2.         Simonneau, G., et al., Clinical classification of pulmonary hypertension. Journal of the American College of Cardiology, 2004. 43(12): p. S5-S12.

3.         McLaughlin, V.V. and M.D. McGoon, Pulmonary arterial hypertension. Circulation, 2006. 114(13): p. 1417-1431.

4.         Tuder, R.M., et al., Development and pathology of pulmonary hypertension. Journal of the American College of Cardiology, 2009. 54(1 Supplement): p. S3-S9.

5.         Tuder, R.M., et al., Pathology of pulmonary hypertension. Clinics in chest medicine, 2007. 28(1): p. 23-42.

6.          Pietra, G.G., et al., Pathologic assessment of vasculopathies in pulmonary hypertension. Journal of the American College of Cardiology, 2004. 43(12): p. S25-S32.

7.         Budhiraja, R., R.M. Tuder, and P.M. Hassoun, Endothelial dysfunction in pulmonary hypertension. Circulation, 2004. 109(2): p. 159-165.

8.         Simonneau, G., et al., Updated clinical classification of pulmonary hypertension. Journal of the American College of Cardiology, 2013. 62(25): p. D34-D41.

9.         Runo, J.R. and J.E. Loyd, Primary pulmonary hypertension. The Lancet, 2003. 361(9368): p. 1533-1544.

10.       Heath, D., W. Whitaker, and J.W. Brown, Idiopathic pulmonary hypertension. British heart journal, 1957. 19(1): p. 83.

11.       Farrar, J., Idiopathic pulmonary hypertension. American heart journal, 1963. 66(1): p. 128-135.

12.       Eliecer, C., et al., 5-Hydroxytryptamine 5-HT2A receptor and 5-hydroxytryptamine transporter polymorphisms in acute myocardial infarction. Clinical Science, 2003. 104(3): p. 241-245.

13.       Lane, K.B., et al., Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension. Nature genetics, 2000. 26(1): p. 81-84.

14.       Speich, R., et al., Primary pulmonary hypertension in HIV infection. Chest, 1991. 100(5): p. 1268-1271.

15.       Mehta, N.J., et al., HIV-related pulmonary hypertension: analytic review of 131 cases. Chest Journal, 2000. 118(4): p. 1133-1141.

16.        Haque, A.K., et al., Pulmonary hypertension in sickle cell hemoglobinopathy: a clinicopathologic study of 20 cases. Human pathology, 2002. 33(10): p. 1037-1043.

17.       Gladwin, M.T., et al., Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. New England Journal of Medicine, 2004. 350(9): p. 886-895.

18.       Farmakis, D. and A. Aessopos, Pulmonary Hypertension Associated With Hemoglobinopathies. Circulation, 2011. 123(11): p. 1227-1232.

19.       Hadengue, A., et al., Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology, 1991. 100(2): p. 520-528.

20.       Robalino, B.D. and D.S. Moodie, Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations. Journal of the American College of Cardiology, 1991. 17(2): p. 492-498.

21.       Levy, D., et al., The progression from hypertension to congestive heart failure. Jama, 1996. 275(20): p. 1557-1562.

22.       Theise, N.D. and P.C. Ursell, Pulmonary Hypertension and Gaucher's Disease: Logical Association or Mere Coincidence? Journal of Pediatric Hematology/Oncology, 1990. 12(1): p. 74-76.

23.       Marvisi, M., et al., Thyroid dysfunction and pulmonary hypertension. Recenti progressi in medicina, 2004. 95(9): p. 443-446.

24.       Levin, D.L., et al., Persistent pulmonary hypertension of the newborn infant. The Journal of pediatrics, 1976. 89(4): p. 626-630.

25.       Murphy, J.D., et al., The structural basis of persistent pulmonary hypertension of the newborn infant. The Journal of pediatrics, 1981. 98(6): p. 962-967.

26.        Mandel, J., E.J. Mark, and C.A. Hales, Pulmonary veno-occlusive disease. American Journal of Respiratory and Critical Care Medicine, 2000. 162(5): p. 1964-1973.

27.       Langleben, D., et al., Familial pulmonary capillary hemangiomatosis resulting in primary pulmonary hypertension. Ann Intern Med, 1988. 109(2): p. 106-109.

28.       Oudiz, R.J., Pulmonary hypertension associated with left-sided heart disease. Clinics in chest medicine, 2007. 28(1): p. 233-241.

29.       Vachiery, J.-L., et al., Pulmonary hypertension due to left heart diseases. Journal of the American College of Cardiology, 2013. 62(25): p. D100-D108.

30.       Chaouat, A., et al., Severe pulmonary hypertension and chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine, 2005. 172(2): p. 189-194.

31.       Joppa, P., et al., Systemic inflammation in patients with COPD and pulmonary hypertension. CHEST Journal, 2006. 130(2): p. 326-333.

32.       Barbero, M., COPD and pulmonary hypertension. Archivos de bronconeumologia, 2008. 45: p. 24-30.

33.       Sanner, B.M., et al., Pulmonary hypertension in patients with obstructive sleep apnea syndrome. Archives of Internal Medicine, 1997. 157(21): p. 2483-2487.

34.       Sajkov, D., et al., Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome. American journal of respiratory and critical care medicine, 1994. 149(2): p. 416-422.

35.       Simonneau, G., et al., Updated clinical classification of pulmonary hypertension. Journal of the American College of Cardiology, 2009. 54(1): p. S43-S54.

36.        Cordova, F.C. and G. D’Alonzo, Sarcoidosis-associated pulmonary hypertension. Current opinion in pulmonary medicine, 2013. 19(5): p. 531-537.

37.       Fartoukh, M., et al., Severe pulmonary hypertension in histiocytosis X. American journal of respiratory and critical care medicine, 2012.

38.       Badesch, D.B., et al., Diagnosis and assessment of pulmonary arterial hypertension. Journal of the American College of Cardiology, 2009. 54(1): p. S55-S66.

39.       Galiè, N., et al., Guidelines for the diagnosis and treatment of pulmonary hypertension. European heart journal, 2009. 30(20): p. 2493-2537.

40.       Nanda, N.C., et al., Echocardiographic evaluation of pulmonary hypertension. Circulation, 1974. 50(3): p. 575-581.

41.       Ahearn, G.S., et al., Electrocardiography to define clinical status in primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular disease. CHEST Journal, 2002. 122(2): p. 524-527.

42.       Zapol, W.M. and M.T. Snider, Pulmonary hypertension in severe acute respiratory failure. New England Journal of Medicine, 1977. 296(9): p. 476-480.

43.       Wessel, D.L., et al., Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics, 1997. 100(5): p. e7-e7.

44.       Fisher, M.R., et al., Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. American journal of respiratory and critical care medicine, 2009. 179(7): p. 615-621.

45.       Naeije, R. and A. Torbicki, More on the noninvasive diagnosis of pulmonary hypertension: Doppler echocardiography revisited. European Respiratory Journal, 1995. 8(9): p. 1445-1449.

46.        Kitabatake, A., et al., Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique. Circulation, 1983. 68(2): p. 302-309.

47.       Roeleveld, R.J., et al., A comparison of noninvasive MRI‐based methods of estimating pulmonary artery pressure in pulmonary hypertension. Journal of Magnetic Resonance Imaging, 2005. 22(1): p. 67-72.

48.       Groepenhoff, H., et al., Exercise testing to estimate survival in pulmonary hypertension. Medicine+ Science in Sports+ Exercise, 2008. 40(10): p. 1725.

49.       Grünig, E., et al., Safety and efficacy of exercise training in various forms of pulmonary hypertension. European Respiratory Journal, 2012. 40(1): p. 84-92.

50.       Denton, C., et al., Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Rheumatology, 1997. 36(2): p. 239-243.

51.       Castro, O., M. Hoque, and B.D. Brown, Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival. Blood, 2003. 101(4): p. 1257-1261.

52.       Yuan, J.X.-J. and L.J. Rubin, Pathogenesis of pulmonary arterial hypertension, 2005, Am Heart Assoc.

53.       Fuso, L., F. Baldi, and A. Di Perna, Therapeutic strategies in pulmonary hypertension. Frontiers in pharmacology, 2011. 2: p. 21.

54.       Naeije, R., et al., Mechanisms of improved arterial oxygenation after peripheral chemoreceptor stimulation during hypoxic exercise. Journal of Applied Physiology, 1993. 74(4): p. 1666-1671.

55.       Rich, S., et al., The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension. Chest, 1998. 114(3): p. 787-792.

56.        Frank, H., et al., The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension. Chest, 1997. 112(3): p. 714-721.

57.       Rich, S., E. Kaufmann, and P.S. Levy, The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. New England Journal of Medicine, 1992. 327(2): p. 76-81.

58.       Badesch, D.B., et al., Prostanoid therapy for pulmonary arterial hypertension. Journal of the American College of Cardiology, 2004. 43(12 Supplement): p. S56-S61.

59.       Galiè, N., A. Manes, and A. Branzi, Prostanoids for pulmonary arterial hypertension. American Journal of Respiratory Medicine, 2003. 2(2): p. 123-137.

60.        Giaid, A., et al., Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. New England Journal of Medicine, 1993. 328(24): p. 1732-1739.

61.        Channick, R.N., et al., Endothelin receptor antagonists in pulmonary arterial hypertension. Journal of the American College of Cardiology, 2004. 43(12 Supplement): p. S62-S67.

62.        Barst, R.J., et al., Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension: open-label pilot study. CHEST Journal, 2002. 121(6): p. 1860-1868.

63.        Ghofrani, H.A., et al., Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension. Journal of the American College of Cardiology, 2004. 43(12): p. S68-S72.

64.        Sebkhi, A., et al., Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension. Circulation, 2003. 107(25): p. 3230-3235.

65.        Travadi, J. and S. Patole, Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn: a review. Pediatric pulmonology, 2003. 36(6): p. 529-535.

66.        Abe, K., et al., Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats. Circulation research, 2004. 94(3): p. 385-393.

67.        Hennigs, J.K., et al., Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension? BMC pulmonary medicine, 2011. 11(1): p. 30.

68.        Murata, T., et al., Statin protects endothelial nitric oxide synthase activity in hypoxia-induced pulmonary hypertension. Arteriosclerosis, thrombosis, and vascular biology, 2005. 25(11): p. 2335-2342.

69.        MacLean, M.R. and Y. Dempsie, Serotonin and pulmonary hypertension—from bench to bedside? Current opinion in pharmacology, 2009. 9(3): p. 281-286.

70.       Hoeper, M., et al., Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension. European Respiratory Journal, 2004. 24(6): p. 1007-1010.

71.       Hoeper, M., et al., Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids. European Respiratory Journal, 2003. 22(2): p. 330-334.

72.       Hoeper, M., et al., Goal-oriented treatment and combination therapy for pulmonary arterial hypertension. European Respiratory Journal, 2005. 26(5): p. 858-863.

73.       Micheletti, A., et al., Role of atrial septostomy in the treatment of children with pulmonary arterial hypertension. Heart, 2006. 92(7): p. 969-972.

74.       Blanc, J., P. Vouhé, and D. Bonnet, Potts shunt in patients with pulmonary hypertension. New England Journal of Medicine, 2004. 350(6): p. 623-623.

75.       Orens, J., et al., Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. International guidelines for the selection of lung transplant candidates: 2006 update—a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant, 2006. 25(7): p. 745-755.

76.        Dandel, M., et al., Strain and strain rate imaging by echocardiography-basic concepts and clinical applicability. Current cardiology reviews, 2009. 5(2): p. 133-148.

77.       Sachdev, A., et al., Right ventricular strain for prediction of survival in patients with pulmonary arterial hypertension. CHEST Journal, 2011. 139(6): p. 1299-1309.

78.       Hsiao, S.-H., et al., Right heart function in scleroderma: insights from myocardial Doppler tissue imaging. Journal of the American Society of Echocardiography, 2006. 19(5): p. 507-514.

79.       Ling, Y., et al., Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. American journal of respiratory and critical care medicine, 2012. 186(8): p. 790-796.

80.       Tüller, C.C., et al., Epidemiology of pulmonary hypertension: new data from the Swiss registry. Swiss medical weekly, 2008. 138(25-26): p. 379-84.

81.       Mukerjee, D., et al., Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Annals of the rheumatic diseases, 2003. 62(11): p. 1088-1093.

 

 

 

 

 

مشخصات مقاله:(در صورتي كه مقاله اي از پايان نامه چاپ يا پذيرش شده است )

 عنوان مقاله:

Longitudinal deformation indices of pulmonary artery in patients with pulmonary venous hypertension

   نويسندگان:

Atoosa Mostafavi  MD, S. A. hussein tabatabaei MD,  Haniye Hajiali MD

 

             نام و شماره مجله :

Accepted on date 13,Aug,2017 in Iranian heart journal



منبع: معاونت پژوهشي دانشکده پزشکي